The summary of product characteristics for Napratec(naproxen 500mg and misoprostol 200ug;Pharmacia)has been updated in line with the minimum clinical particulars for non-steroidal anti-inflammatory drugs as requested by the Medicines and Healthcare products Regulatory Agency.Regular monitoring of elderly patients for adverse effects is now recommended,as they are at increased risk of gastrointestinal bleeding.
展开▼
